Thalidomide and thrombosis in patients with multiple myelomaCAMBA, Lionello; PECCATORI, Jacopo; PESCAROLLO, Alessandra et al.Haematologica (Roma). 2001, Vol 86, Num 10, pp 1108-1109, issn 0390-6078Article

Atypical presentation of Churg-Strauss syndrome or an undescribed hypereosinophilic disease?DELLA-TORRE, Emanuel; TRESOLDI, Moreno; SCOTTI, Raffaella et al.Journal of allergy and clinical immunology. 2011, Vol 128, Num 4, pp 908-911, issn 0091-6749, 4 p.Article

MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells costimulates pamidronate-activated γδ lymphocytesGIRLANDA, Stefania; FORTIS, Claudio; CALIGARIS CAPPIO, Federico et al.Cancer research (Baltimore). 2005, Vol 65, Num 16, pp 7502-7508, issn 0008-5472, 7 p.Article

Immunohistochemical evidence of a cytokine and chemokine network in three patients with erdheim-chester disease : Implications for pathogenesisSTOPPACCIARO, Antonella; FERRARINI, Marina; SALMAGGI, Chiara et al.Arthritis and rheumatism. 2006, Vol 54, Num 12, pp 4018-4022, issn 0004-3591, 5 p.Article

Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patientsPRUNERI, Giancarlo; PONZONI, Maurilio; NERI, Antonino et al.British journal of haematology. 2002, Vol 118, Num 3, pp 817-820, issn 0007-1048Article

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignanciesCORRADINI, Paolo; TARELLA, Corrado; CICERI, Fabio et al.Blood. 2002, Vol 99, Num 1, pp 75-82, issn 0006-4971Article